Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A glossary toggle ('Show glossary') was added and the update-label capitalization adjusted. The footer now shows 'Revision: v3.4.0' replacing 'v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T22:56:32.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.3 to v3.3.4; this does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:49:03.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Added a Locations section with California as a study location and updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:14:34.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2. This appears to be an administrative metadata change rather than any modification to study details or content.
    Difference
    0.1%
    Check dated 2025-12-01T17:38:48.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and v3.2.0 was removed; this is a minor version-label update that does not alter study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:44:51.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Removed the government funding status notice/banner indicating potential delays and NIH operating status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:20:36.000Z thumbnail image

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.